Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 4/21/2016 |
| Start Date: | April 2009 |
| End Date: | July 2015 |
The Study plan is a post-market prospective, multi-center, open-label registry. The vein
graft failure rates for the currently commercialized C-Port devices will be compared to an a
priori rate taken from the peer-reviewed literature.
graft failure rates for the currently commercialized C-Port devices will be compared to an a
priori rate taken from the peer-reviewed literature.
To satisfy the requirements set forth in post-market surveillance orders issued by the US
FDA to Cardica, Inc., the following outcomes will be evaluated:
1. Acute, midterm, and one-year graft failure rates for coronary revascularization using
the C-Port® xA™ Distal Anastomosis System, C-Port® FlexA™ Distal Anastomosis System,
and C-Port® XCHANGE™ Distal Anastomosis System when in general use in the United States
compared to hand-sewn anastomoses.
2. Technical failure rates when attempting to complete an anastomosis using the C-Port xA,
FlexA, and XCHANGE Distal Anastomosis Systems.
3. The technical success rate of hand-sewn anastomoses following technical failures of the
C-Port devices and the hand-sewn graft patency rates and clinical sequelae at one year.
FDA to Cardica, Inc., the following outcomes will be evaluated:
1. Acute, midterm, and one-year graft failure rates for coronary revascularization using
the C-Port® xA™ Distal Anastomosis System, C-Port® FlexA™ Distal Anastomosis System,
and C-Port® XCHANGE™ Distal Anastomosis System when in general use in the United States
compared to hand-sewn anastomoses.
2. Technical failure rates when attempting to complete an anastomosis using the C-Port xA,
FlexA, and XCHANGE Distal Anastomosis Systems.
3. The technical success rate of hand-sewn anastomoses following technical failures of the
C-Port devices and the hand-sewn graft patency rates and clinical sequelae at one year.
Inclusion Criteria:
- Able to give informed consent.
- Willing and able to have follow-up visits and examinations.
- Less than 80 years old.
- Have an ejection fraction of >30 %.
- Have a life expectancy of >1 year.
Pre-Operative Exclusion Criteria:
- Currently participating in other clinical trials that would conflict with this
protocol.
- Unable to meet study requirements.
- Currently pregnant.
- Require preoperative use of an intraaortic balloon pump.
- Have a history of a bleeding disorder or history of a thromboembolic disease
requiring anticoagulation therapy.
- Have congestive heart failure or been classified as NYHA Class IV.
- Have an aspirin allergy or other contraindications to aspirin use.
- Previous coronary artery bypass surgery.
- Vasculitis or other nonatherosclerotic cause for coronary artery disease.
Intra-Operative Exclusion Criteria:
- At least one target vessel site where the C-Port anastomosis will be placed that is
free from severe calcification or severe atheromas
- Target vessel wall properties where the C-Port anastomosis will be placed are
suitable for hand-sewn anastomosis
- Target vessel diameter is ≥ 1.3 mm
- Target vessel has a single wall thickness ≤ 0.75mm
- Hemodynamically stable
We found this trial at
7
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Akron General Medical Center It
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials